| Literature DB >> 36171015 |
Kristina B Slåtsve1,2, Tor Claudi3, Knut Tore Lappegård3,2, Anne Karen Jenum4, Marthe Larsen5, Kjersti Nøkleby4, Katrina Tibballs4, John G Cooper6,7, Sverre Sandberg7, Esben Selmer Buhl4, Karianne Fjeld Løvaas7, Tore Julsrud Berg8,9.
Abstract
INTRODUCTION: To study the relationship between education level and vascular complications in individuals with type 2 diabetes in Norway. RESEARCH DESIGN AND METHODS: Multiregional population-based cross-sectional study of individuals with type 2 diabetes in primary care. Data were extracted from electronic medical records in the period 2012-2014. Information on education level was obtained from Statistics Norway. Using multivariable multilevel regression analyses on imputed data we analyzed the association between education level and vascular complications. We adjusted for age, sex, HbA1c, low-density lipoprotein cholesterol, systolic blood pressure, smoking and diabetes duration. Results are presented as ORs and 95% CIs.Entities:
Keywords: Coronary Artery Disease; Diabetes Mellitus, Type 2; Education; Kidney Diseases
Mesh:
Substances:
Year: 2022 PMID: 36171015 PMCID: PMC9528574 DOI: 10.1136/bmjdrc-2022-002867
Source DB: PubMed Journal: BMJ Open Diabetes Res Care ISSN: 2052-4897
General characteristics of individuals with type 2 diabetes according to education level
| Compulsory education, n=2789 | Upper secondary education, n=4016 | Higher education, n=1387 | ||||
| Valid numbers, n (%) | Valid numbers, n (%) | Valid numbers, n (%) | ||||
| Patient characteristics | ||||||
| Age (years), mean (SD) | 2789 (100) | 69.1 (13.8) | 4016 (100) | 67.4 (12.1) | 1387 (100) | 65.4 (11.8) |
| Men, n (%) | 2789 (100) | 1289 (46.2) | 4016 (100) | 2350 (58.5) | 1387 (100) | 874 (63.0) |
| Diabetes duration (years), median (IQR) | 2620 (93.9) | 8 (3–13) | 3796 (94.5) | 7 (3–12) | 1326 (95.6) | 7 (3–12) |
| Age at diagnosis (years), median (IQR) | 2620 (93.9) | 61 (50–69) | 3796 (94.5) | 59 (51–67) | 1326 (95.6) | 58 (50–65) |
| BMI (kg/m2), mean (SD) | 1255 (50.0) | 30.5 (6.3) | 1918 (47.8) | 30.2 (5.8) | 674 (48.6) | 29.7 (5.7) |
| Smoking, n (%) | 2260 (81.0) | 642 (28.4) | 3258 (81.1) | 707 (21.7) | 1102 (79.5) | 157 (14.3) |
| Cardiovascular risk factors | ||||||
| HbA1c, %, mean (SD) | 2707 (97.1) | 7.0 (1.2) | 3885 (96.7) | 6.9 (1.1) | 1336 (96.3) | 6.9 (1.1) |
| HbA1c, mmol/mol, mean (SD) | 2708 (97.1) | 53 (13) | 3886 (96.7) | 52 (12) | 1336 (96.3) | 52 (12) |
| Systolic blood pressure, mm Hg, mean (SD) | 2428 (87.1) | 137 (17) | 3537 (87.9) | 136 (16) | 1214 (87.4) | 135 (15) |
| Diastolic blood pressure, mm Hg, mean (SD) | 2428 (87.1) | 77 (10) | 3537 (87.9) | 78 (9) | 1214 (87.4) | 79 (9) |
| LDL-cholesterol, mmol/L, mean (SD) | 2285 (81.9) | 2.8 (1.0) | 3380 (84.2) | 2.7 (0.9) | 1170 (84.4) | 2.8 (0.9) |
| Prescribed medication | ||||||
| Insulin, n (%) | 2789 (100) | 549 (19.7) | 4016 (100) | 673 (16.8) | 1387 (100) | 181 (13.0) |
| Per oral glucose lowering, n (%) | 2789 (100) | 1856 (66.6) | 4016 (100) | 2667 (66.4) | 1387 (100) | 874 (63.0) |
| Lipid-lowering medication, n (%) | 2789 (100) | 1723 (61.8) | 4016 (100) | 2496 (62.2) | 1387 (100) | 796 (57.4) |
| Lipid-lowering medication with CHD, n (%) | 721 (100*) | 595 (82.5) | 920 (100*) | 800 (87.0) | 234 (100*) | 202 (86.3) |
| Lipid-lowering medication with no CHD, n (%) | 2060 (73.9*) | 1123 (54.5) | 3086 (76.8*) | 1689 (54.7) | 1150 (82.9*) | 593 (51.6) |
| Acetylsalicylic acid, n (%) | 2789 (100) | 1200 (43.0) | 4016 (100) | 1577 (39.3) | 1387 (100) | 500 (36.1) |
| Vascular complications | ||||||
| Coronary heart disease, n (%) | 2781 (99.7) | 721 (25.9) | 4006 (99.8) | 920 (23.0) | 1384 (99.8) | 234 (16.9) |
| Stroke, n (%) | 2786 (99.9) | 266 (9.6) | 4008 (99.8) | 296 (7.4) | 1385 (99.9) | 91 (6.6) |
| Chronic kidney disease, eGFR<60 mL/min/1.73 m2, n (%) | 2662 (95.4) | 635 (23.9) | 3813 (94.9) | 640 (16.8) | 1297 (93.5) | 163 (12.6) |
| Retinopathy, all, n (%) | 1669 (59.8) | 132 (13.9) | 2496 (62.2) | 288 (11.5) | 888 (64.0) | 104 (11.7) |
| Foot complications | 2789 (100) | 166 (6.0) | 4016 (100) | 207 (5.2) | 1387 (100) | 49 (3.5) |
| PTA/arterial surgery, n (%) | 2779 (99.6) | 67 (2.4) | 3996 (99.5) | 96 (2.4) | 1382 (99.6) | 17 (1.2) |
| History of foot ulcer, n (%) | 2785 (99.9) | 101 (3.6) | 4009 (99.8) | 121 (3.0) | 1387 (100) | 37 (2.7) |
| Lower limb amputations, n (%) | 2787 (100) | 25 (0.9) | 4011 (99.9) | 38 (0.9) | 1386 (100) | 6 (0.4) |
*Per cent of subpopulation with/without CHD and prescribed/not prescribed lipid-lowering medication.
BMI, body mass index; CHD, coronary heart disease; eGFR, estimated glomerular filtration rate; LDL, low-density lipoprotein; PTA, percutaneous transluminal angioplasty.
Figure 1Number of vascular complications in adults with type 2 diabetes in Norway according to education level. Complications as defined in table 1. More than three complications: compulsory education, 0.8%; upper secondary education, 0.4%; higher education, 0.2%.
OR and 95% CI for having vascular complications in patients with type 2 diabetes, by education level
| Unadjusted | Model 1 | Model 2 | ||||
| OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
|
| ||||||
| Education level | <0.001 | <0.001 | <0.001 | |||
| Compulsory education | 1 | 1 | 1 | |||
| Upper secondary education | 0.86 (0.77 to 0.96) | 0.007 | 0.84 (0.74 to 0.95) | 0.004 | 0.83 (0.73 to 0.93) | 0.003 |
| Higher education | 0.59 (0.50 to 0.69) | <0.001 | 0.58 (0.49 to 0.70) | <0.001 | 0.59 (0.49 to 0.71) | <0.001 |
|
| ||||||
| Education level | 0.001 | 0.037 | 0.066 | |||
| Compulsory education | 1 | 1 | 1 | |||
| Upper secondary education | 0.75 (0.63 to 0.90) | 0.001 | 0.81 (0.68 to 0.97) | 0.021 | 0.81 (0.68 to 0.97) | 0.025 |
| Higher education | 0.67 (0.52 to 0.86) | 0.001 | 0.78 (0.60 to 1.01) | 0.061 | 0.82 (0.63 to 1.07) | 0.141 |
|
| ||||||
| Education level | <0.001 | 0.006 | 0.008 | |||
| Compulsory education | 1 | 1 | 1 | |||
| Upper secondary education | 0.64 (0.57 to 0.73) | <0.001 | 0.83 (0.72 to 0.96) | 0.010 | 0.83 (0.72 to 0.96) | 0.010 |
| Higher education | 0.46 (0.39 to 0.56) | <0.001 | 0.74 (0.60 to 0.92) | 0.006 | 0.75 (0.60 to 0.93) | 0.009 |
|
| ||||||
| Education level | 0.097 | 0.025 | 0.166 | |||
| Compulsory education | 1 | 1 | 1 | |||
| Upper secondary education | 0.84 (0.70 to 0.99) | 0.048 | 0.80 (0.67 to 0.95) | 0.012 | 0.84 (0.69 to 1.01) | 0.061 |
| Higher education | 0.85 (0.67 to 1.07) | 0.154 | 0.80 (0.63 to 1.01) | 0.058 | 0.91 (0.70 to 1.17) | 0.442 |
|
| ||||||
| Education level | 0.003 | 0.005 | 0.068 | |||
| Compulsory education | 1 | 1 | 1 | |||
| Upper secondary education | 0.85 (0.69 to 1.05) | 0.128 | 0.84 (0.68 to 1.04) | 0.113 | 0.89 (0.72 to 1.11) | 0.306 |
| Higher education | 0.57 (0.41 to 0.79) | 0.001 | 0.58 (0.42 to 0.81) | 0.001 | 0.67 (0.48 to 0.94) | 0.021 |
Model 1 is adjusted for age and sex, and model 2 is adjusted for age, sex, HbA1c, low-density lipoprotein (LDL)-cholesterol, systolic blood pressure, smoking and diabetes duration. County is included as a random effect in all models, and the analyses are done on imputed data.
eGFR, estimated glomerular filtration rate.